Silk Road Medical Inc(SILK) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.

Current Price

$51.31

RSI

22.004

Beta:

1.392071

March 01, 2021
48.5M
-14.5M

10.369 %
4.957 %
-102.099 %
-37.946 %

$69,645,000
$58,402,000
$34,557,000
$14,258,000
19.251 %
69.002 %
142.369 %

$-47,354,000
$-52,407,000
$-37,630,000
$-19,356,000
10.671 %
-28.197 %
-48.562 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.